Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B

  • Chanthra, Nawin (Research Unit of Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University) ;
  • Payungporn, Sunchai (Research Unit of Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University) ;
  • Chuaypen, Natthaya (Research Unit of Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University) ;
  • Pinjaroen, Nutcha (Department of Radiology, Faculty of Medicine, Chulalongkorn University) ;
  • Poovorawan, Yong (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Tangkijvanich, Pisit (Research Unit of Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University)
  • Published : 2015.07.13
Download PDF
⟨ Previous Next ⟩

Abstract

The single nucleotide polymorphism (SNP) rs1053004 in Signal transducer and activator of transcription 3 (STAT3) was recently reported to be associated with chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC) in a Chinese cohort. This study was aimed at investigating whether the SNP might also contribute to HCC susceptibility in the Thai population. Study subjects were enrolled and divided into 3 groups including CHB-related HCC (n=211), CHB without HCC (n=233) and healthy controls (n=206). The SNP was genotyped using allelic discrimination assays based on TaqMan real-time PCR. Data analysis revealed that the distribution of different genotypes was in Hardy-Weinberg equilibrium (P>0.05). The frequencies of allele T (major allele) in HCC patients, CHB patients and healthy controls were 51.4%, 58.6% and 61.4%, respectively, whereas the frequencies of C allele (minor allele) were 48.6%, 41.4% and 38.6%. The C allele frequency was higher in HCC when compared with CHB patients (odds ratio (OR)=1.34, 95% confidence interval (CI)=1.02-1.74, P=0.032). The genotype of SNP rs1053004 (CC versus TT+TC) was significantly associated with an increased risk when compared with CHB patients (OR=1.83, 95% CI=1.13-2.99, P=0.015). In addition, we observed a similar trend of association when comparing HCC patients with healthy controls (OR=1.77, 95% CI=1.07-2.93, P=0.025) and all controls (OR=1.81, 95% CI=1.19-2.74, P=0.005). These findings suggest that the SNP rs1053004 in STAT3 might contribute to HCC susceptibility and could be used as a genetic marker for HCC in the Thai population.

Keywords

References

  1. Bjornstrom L, Sjoberg M (2002). Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol, 16, 2202-14. https://doi.org/10.1210/me.2002-0072
  2. Bruix J, Sherman M (2005). Diagnosis of small HCC. Gastroenterology, 129, 1364. https://doi.org/10.1053/j.gastro.2005.08.046
  3. Chen T, Wang LH, Farrar WL (2000). Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res, 60, 2132-5.
  4. Chittmittrapap S, Chieochansin T, Chaiteerakij R, et al (2013). Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg). Asian Pac J Cancer Prev, 14, 7675-9. https://doi.org/10.7314/APJCP.2013.14.12.7675
  5. Choudhari SR, Khan MA, Harris G, et al (2007). Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod. Mol Cancer Ther, 6, 112-21.
  6. Eto M, Kamba T, Miyake H, et al (2013). STAT3 polymorphism can predict the response to interferon-alpha therapy in patients with metastatic renal cell carcinoma. Eur Urol, 63, 745-52. https://doi.org/10.1016/j.eururo.2012.09.052
  7. Foshay KM, Gallicano GI (2009). miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol, 326, 431-43. https://doi.org/10.1016/j.ydbio.2008.11.016
  8. Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma-current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
  9. Hou J, Xu J, Jiang R, et al (2013). Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology, 57, 678-88. https://doi.org/10.1002/hep.25980
  10. Jee SH, Ohrr H, Sull JW, et al (2004). Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst, 96, 1851-6. https://doi.org/10.1093/jnci/djh334
  11. Messaoudi S, Hizem S, Al-Sulaiti MA, et al (2013a). Contribution of JAK2 and STAT3 variants to the genetic susceptibility of recurrent spontaneous miscarriage in a Tunisian population. Genet Test Mol Biomarkers, 17, 35-9. https://doi.org/10.1089/gtmb.2012.0201
  12. Messoudi S, Al-Sulaiti MA, Al-Busaidi AS, et al (2013b). Contribution of JAK2 and STAT3 variants to the genetic susceptibility of recurrent miscarriage among Bahraini and Tunisian Arabs. Mol Biol Rep, 40, 585-9. https://doi.org/10.1007/s11033-012-2096-8
  13. Migone TS, Lin JX, Cereseto A, et al (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science, 269, 79-81. https://doi.org/10.1126/science.7604283
  14. Muromoto R, Ikeda O, Okabe K, et al (2009). Epstein-Barr virus-derived EBNA2 regulates STAT3 activation. Biochem Biophys Res Commun, 378, 439-43. https://doi.org/10.1016/j.bbrc.2008.11.053
  15. Nguyen KB, Watford WT, Salomon R, et al (2002). Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science, 297, 2063-6. https://doi.org/10.1126/science.1074900
  16. Shi L, Feng Y, Lin H, et al (2014). Role of estrogen in hepatocellular carcinoma: is inflammation the key? J Transl Med, 12, 93. https://doi.org/10.1186/1479-5876-12-93
  17. Sopipong W, Tangkijvanich P, Payungporn S, et al (2013). The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients. Asian Pac J Cancer Prev, 14, 2865-9. https://doi.org/10.7314/APJCP.2013.14.5.2865
  18. Subramaniam A, Shanmugam MK, Perumal E, et al (2013). Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta, 1835, 46-60.
  19. Sun S, Steinberg BM (2002). PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol, 83, 1651-8. https://doi.org/10.1099/0022-1317-83-7-1651
  20. Thongbai C, Sa-nguanmoo P, Kranokpiruk P, et al (2013). Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand. Asian Pac J Cancer Prev, 14, 3555-9. https://doi.org/10.7314/APJCP.2013.14.6.3555
  21. Wang K, Zhou B, Zhang J, et al (2011). Association of signal transducer and activator of transcription 3 gene polymorphisms with cervical cancer in Chinese women. DNA Cell Biol, 30, 931-6. https://doi.org/10.1089/dna.2010.1179
  22. Waris G, Siddiqui A (2002). Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol, 76, 2721-9. https://doi.org/10.1128/JVI.76.6.2721-2729.2002
  23. Xie J, Zhang Y, Zhang Q, et al (2013). Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma. Hepatology, 57, 2369-77. https://doi.org/10.1002/hep.26303
  24. Yu H, Jove R (2004). The STATs of cancer--new molecular targets come of age. Nat Rev Cancer, 4, 97-105. https://doi.org/10.1038/nrc1275
  25. Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809. https://doi.org/10.1038/nrc2734
  26. Yuan K, Liu H, Huang L, et al (2014). rs744166 polymorphism of the STAT3 gene is associated with risk of gastric cancer in a Chinese population. Biomed Res Int, 2014, 527918.

Cited by

  1. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.2019
  2. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma vol.88, pp.9, 2016, https://doi.org/10.1002/jmv.24498
  3. Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population vol.19, pp.1, 2018, https://doi.org/10.1186/s12881-018-0569-x